TXG (NASDAQ) - 10X Genomics Inc

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US88025U1097
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell Assay for Transposase Accessible Chromati (ATAC) for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California. Web URL: https://www.10xgenomics.com

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for TXG (NASDAQ) - 10X Genomics Inc


Market Cap in USD 6,053m
Sector Healthcare
Industry Health Information Services
GiC SubIndustry Life Sciences Tools & Services
TER 0.00%
IPO / Inception 2019-09-12


Fundamental -5.14
Dividend -
Performance 5y 0.50
Rel. Performance vs Sector -2.00
Analysts 4.00
Fair Price Total Ret. 37.07
Fair Price DCF todo


Growth TTM 41.52%
CAGR 5y 1.37%
CAGR / Mean Drawdown 5y 0.03
Sharpe Ratio TTM 0.55
Alpha vs SP500 TTM 9.31
Beta vs SP500 5y weekly 1.67
CAPM 8.90%
Average Daily Range 2m 3.70%
Reversal Oscillator 3.47
Volatility GJR Garch 1y 54.47%
Price / SMA 50 -20.86%
Price / SMA 200 -17.12%
Current Volume 1039.3k
Average Volume 20d 968.1k


Yield TTM 0.00%
Yield on Cost 5y 0.00%
Dividends CAGR 5y 0.00%
Consistency of Dividends all time 0.0%